Reasonable Hypothesis SOP [1] | 11 of 2016 |
Balance of Probabilities SOP [2] | 12 of 2016 |
SOP Bulletin 188 [3]
This SOP covers cancer of the lining of the uterus.
Diagnosis requires histological examination of tissue obtained from endometrial biopsy, a dilation and curettage procedure, or surgical removal.
The relevant medical specialist is a gynaecologist or gynaecological oncologist.
*another SOP applies, # nonSOP
Clinical onset will be when the condition was first diagnosed. It may be possible to backdate onset to the start of of relevant symptoms that led to the diagnosis, however such symptoms, e.g. bleeding or pain, may be non-specific.
The SOP has only an inability to obtain apropriate clinical management factor for worsening. Timely treatment can alter the course of the condition. Establishing whether worsening beyond the normal course of the disease has occurred will generally require expert medical opinion.
Place holder node for Rulebase for malignant neoplasm of the endometrium
Malignant neoplasm of the endometrium - A course of therapeutic radiation involving the pelvic organs Factor
Last reviewed for CCPS 30 April 1997.
Preliminary questions [14042]
16834 [5] there is some evidence that therapeutic radiation involving the pelvic organs may be a factor in the development of the condition under consideration.
1169 — the veteran is a woman. [6] the veteran has had a course of therapeutic radiation involving the pelvic organs at some time.
14063 [7] the course of therapeutic radiation involving the pelvic organs was given for treatment of an illness or injury which is identifiable. the veteran received the course of therapeutic radiation to the pelvic organs for treatment of the identified illness or injury before the clinical onset of malignant neoplasm of the endometrium. [9]
14065 — the veteran has established the causal connection between the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given and VEA service for the clinical onset of malignant neoplasm of the endometrium.
14066 — the veteran has established the causal connection between the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given and operational service for the clinical onset of malignant neoplasm of the endometrium.
or
14067 — the veteran has established the causal connection between the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given and eligible service for the clinical onset of malignant neoplasm of the endometrium.
Clinical onset and operational service [14066]
14068 — the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given is causally related to operational service. [10] [11]
Clinical onset and eligible service [14067]
14069 — the identified illness or injury for which the course of therapeutic radiation involving the pelvic organs was given is causally related to eligible service. [12] [11]
Malignant neoplasm of the endometrium - Being nulliparous Factor
Last reviewed for CCPS 30 April 1997.
Investigative Documents
Medical Report - Being Nulliparous - Malignant Neoplasm of the Endometrium [MR9085] Preliminary questions [14038]
1169 — the veteran is a woman. [6] the veteran was nulliparous immediately before the clinical onset of the condition under consideration. the veteran's nulliparous state immediately before the clinical onset of the condition under consideration was substantially attributable to the taking of oral contraceptives containing oestrogen and progestogen. the veteran was nulliparous immediately before the clinical onset of the condition under consideration because of an illness or injury which is identifiable. [17]
14098 — the veteran has established the causal connection between being nulliparous and VEA service for the clinical onset of malignant neoplasm of the endometrium.
14099 — the veteran has established the causal connection between being nulliparous and operational service for the clinical onset of malignant neoplasm of the endometrium.
or
14100 — the veteran has established the causal connection between being nulliparous and eligible service for the clinical onset of malignant neoplasm of the endometrium.
Clinical onset and operational service [14099]
8870 — the identified illness or injury which caused the veteran to be nulliparous is causally related to operational service. [18] [19]
Clinical onset and eligible service [14100]
14101 — the identified illness or injury which caused the veteran to be nulliparous is causally related to eligible service. [20] [19]
Malignant neoplasm of the endometrium - Hormonal replacement therapy Factor
Last reviewed for CCPS 30 April 1997.
Investigative Documents
Medical Report - Hormone Replacement Medication - Malignant Neoplasm of the Endometrium [MR9086] Preliminary questions [14041]
8813 [24] the veteran has undergone a course of hormone replacement medication consisting of oestrogen unopposed by progesterone at some time. the course of hormone replacement medication consisting of oestrogen unopposed by progesterone was undergone for treatment of an illness or injury which is identifiable. the veteran underwent the course of hormone replacement medication consisting of oestrogen unopposed by progesterone for treatment of the identified illness or injury before the clinical onset of malignant neoplasm of the endometrium. [27]
14103 — the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and VEA service for the clinical onset of malignant neoplasm of the endometrium.
14104 — the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and operational service for the clinical onset of malignant neoplasm of the endometrium.
or
14105 — the veteran has established the causal connection between the identified illness or injury for which the course of hormone replacement medication was undergone and eligible service for the clinical onset of malignant neoplasm of the endometrium.
Clinical onset and operational service [14104]
8823 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to operational service. [28] [29]
Clinical onset and eligible service [14105]
8824 — the identified illness or injury, for which the veteran had hormone replacement therapy, is causally related to eligible service. [30] [29]
Malignant neoplasm of the endometrium - No appropriate clinical management for malignant neoplasm of endometrium Factor
Last reviewed for CCPS 30 April 1997.
Investigative Documents
Medical Report - Inability to Obtain Appropriate Clinical Management - [GQACM] Preliminary questions [14044]
1169 — the veteran is a woman. [6] the clinical onset of malignant neoplasm of the endometrium occurred after the end of the veteran's last period of VEA service. the veteran's malignant neoplasm of the endometrium permanently worsened. the veteran was unable to obtain appropriate clinical management for malignant neoplasm of the endometrium at some time.
14080 [35] an inability to obtain appropriate clinical management for malignant neoplasm of the endometrium contributed to the clinical worsening of the veteran's malignant neoplasm of the endometrium. 14082 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for malignant neoplasm of the endometrium and VEA service for the clinical worsening of malignant neoplasm of the endometrium. 14083 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for malignant neoplasm of the endometrium and operational service for the clinical worsening of malignant neoplasm of the endometrium. or 14084 — the veteran has established the causal connection between the inability to obtain appropriate clinical management for malignant neoplasm of the endometrium and eligible service for the clinical worsening of malignant neoplasm of the endometrium. Clinical worsening and operational service [14083] or 14091 — the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for malignant neoplasm of the endometrium is causally related to operational service. [40] [41] Clinical worsening and eligible service [14084] or 14092 — the identified illness or injury that prevented the veteran from obtaining appropriate clinical management for malignant neoplasm of the endometrium is causally related to eligible service. [40] [41]
Malignant neoplasm of the endometrium - Obesity Factor
Last reviewed for CCPS 30 April 1997.
Investigative Documents
Claimant Report - Obesity [CR9230] [48] Medical Report - Obesity [MR9305] Preliminary questions [14043]
1169 — the veteran is a woman. [6] the veteran has a history of obesity. 14071 — the veteran has established the causal connection between the obesity and VEA service for the clinical onset of malignant neoplasm of the endometrium. 14072 — the veteran has established the causal connection between the obesity and operational service for the clinical onset of malignant neoplasm of the endometrium. or 14073 — the veteran has established the causal connection between the obesity and eligible service for the clinical onset of malignant neoplasm of the endometrium. Clinical onset and operational service [14072] or
9005 — the morbid obesity is causally related to operational service. [54] Clinical onset and eligible service [14073] or
9006 — the morbid obesity is causally related to eligible service. [58] [59]
Malignant neoplasm of the endometrium - Stein-Leventhal syndrome Factor
Last reviewed for CCPS 30 April 1997.
Preliminary questions [14039]
16832 [60] there is some evidence that Stein-Leventhal syndrome may be a factor in the development of the condition under consideration.
1169 — the veteran is a woman. [6] the veteran has suffered from Stein-Leventhal syndrome at some time.
14046 [61] the veteran suffered from Stein-Leventhal syndrome before the clinical onset of malignant neoplasm of the endometrium. [62]
14047 — the veteran has established the causal connection between the Stein-Leventhal syndrome and VEA service for the clinical onset of malignant neoplasm of the endometrium.
14050 — the veteran has established the causal connection between the Stein-Leventhal syndrome and operational service for the clinical onset of malignant neoplasm of the endometrium.
or
14051 — the veteran has established the causal connection between the Stein-Leventhal syndrome and eligible service for the clinical onset of malignant neoplasm of the endometrium.
Clinical onset and operational service [14050]
14052 — the Stein-Leventhal syndrome is causally related to operational service. [63] [64]
Clinical onset and eligible service [14051]
14053 — the Stein-Leventhal syndrome is causally related to eligible service. [65] [64]
Malignant neoplasm of the endometrium - Treatment with tamoxifen Factor
Last reviewed for CCPS 30 April 1997.
Preliminary questions [14040]
16833 [66] there is some evidence that treatment with tamoxifen may be a factor in the development of the condition under consideration.
1169 — the veteran is a woman. [6] the veteran has been treated with tamoxifen at some time.
14056 [67] the treatment with tamoxifen was given for an illness or injury which is identifiable. 14057 — the veteran has established the causal connection between the identified illness or injury for which the treatment with tamoxifen was given and VEA service for the clinical onset of malignant neoplasm of the endometrium. 14058 — the veteran has established the causal connection between the identified illness or injury for which the treatment with tamoxifen was given and operational service for the clinical onset of malignant neoplasm of the endometrium. or 14059 — the veteran has established the causal connection between the identified illness or injury for which the treatment with tamoxifen was given and eligible service for the clinical onset of malignant neoplasm of the endometrium. Clinical onset and operational service [14058] 14060 — the identified illness or injury for which the treatment with tamoxifen was given is causally related to operational service. [69] [70] Clinical onset and eligible service [14059]
14061 — the identified illness or injury for which the treatment with tamoxifen was given is causally related to eligible service. [73] [70]
Links
[1] http://www.rma.gov.au/assets/SOP/2016/011.pdf
[2] http://www.rma.gov.au/assets/SOP/2016/012.pdf
[3] https://clik.dva.gov.au/system/files/media/SOP%20Bulletin%20188.pdf
[4] https://clik.dva.gov.au/user/login?destination=comment/reply/63764%23comment-form
[5] clikpopup://CCPS/A course of therapeutic radiation involving the pelvic organs
[6] clikpopup://CCPS/reject1169No
[7] clikpopup://CCPS/Therapeutic radiation for treatment of identifiable illness
[8] clikpopup://CCPS/reject14063No
[9] clikpopup://CCPS/reject14064No
[10] clikpopup://CCPS/reject14068No
[11] clikpopup://CCPS/reject14068,14069No
[12] clikpopup://CCPS/reject14069No
[13] https://clik.dva.gov.au/node/75169
[14] https://clik.dva.gov.au/nulliparous
[15] https://clik.dva.gov.au/reasons-decision-152
[16] clikpopup://CCPS/reject14096Yes
[17] clikpopup://CCPS/reject14097No
[18] clikpopup://CCPS/reject8870No
[19] clikpopup://CCPS/reject8870,14101No
[20] clikpopup://CCPS/reject14101No
[21] https://clik.dva.gov.au/ccpsmedical-90
[22] clikpopup://CCPS/reject1169Yes
[23] https://clik.dva.gov.au/ccpsg022rc-6
[24] clikpopup://CCPS/HRT consisting of oestrogen unopposed by progesterone at some time
[25] clikpopup://CCPS/reject8813No
[26] clikpopup://CCPS/reject8814No
[27] clikpopup://CCPS/reject14102No
[28] clikpopup://CCPS/reject8823No
[29] clikpopup://CCPS/reject8823,8824No
[30] clikpopup://CCPS/reject8824No
[31] https://clik.dva.gov.au/ccpsother-31
[32] https://clik.dva.gov.au/node/71034
[33] clikpopup://CCPS/Reject/OnsetAfterService
[34] clikpopup://CCPS/Reject/NoPermanentWorsening
[35] clikpopup://CCPS/Malignant neoplasm of the endometrium/ACM - contributed to worsening
[36] clikpopup://CCPS/ACM/NoContribution
[37] clikpopup://CCPS/ACM/NotOpService
[38] clikpopup://CCPS/ACM/NotOperDuties
[39] clikpopup://CCPS/rejectwilful
[40] clikpopup://CCPS/ACM/NoIllness
[41] clikpopup://CCPS/reject14091,14092No
[42] clikpopup://CCPS/Malignant neoplasm of the endometrium/ACM - onset prior to operational service
[43] clikpopup://CCPS/ACM/OnsetFailOper
[44] clikpopup://CCPS/ACM/NotEligService
[45] clikpopup://CCPS/ACM/NotEligDuties
[46] clikpopup://CCPS/Malignant neoplasm of the endometrium/ACM - onset prior to eligible service
[47] clikpopup://CCPS/ACM/OnsetFailElig
[48] https://clik.dva.gov.au/ccpsclaimant-78
[49] https://clik.dva.gov.au/ccpsb045rc-0
[50] clikpopup://CCPS/reject587No
[51] clikpopup://CCPS/reject14074No
[52] clikpopup://CCPS/reject591No
[53] clikpopup://CCPS/reject9004No
[54] clikpopup://CCPS/reject9005No
[55] clikpopup://CCPS/Obesity present for 20 years prior to onset of malignant neoplasm of the endometrium
[56] clikpopup://CCPS/reject14075No
[57] clikpopup://CCPS/reject3407No
[58] clikpopup://CCPS/reject9006No
[59] clikpopup://CCPS/reject9005,9006No
[60] https://clik.dva.gov.au/stein-leventhal-syndrome
[61] clikpopup://CCPS/Stein-Leventhal syndrome present prior to onset of malignant neoplasm of the endometrium
[62] clikpopup://CCPS/reject14046No
[63] clikpopup://CCPS/reject14052No
[64] clikpopup://CCPS/reject14052,14053No
[65] clikpopup://CCPS/reject14053No
[66] https://clik.dva.gov.au/ccpsb009rc-23
[67] clikpopup://CCPS/Tamoxifen for treatment of identifiable illness
[68] clikpopup://CCPS/reject14056No
[69] clikpopup://CCPS/reject14055No
[70] clikpopup://CCPS/reject14060,14061No
[71] clikpopup://CCPS/Took tamoxifen for one year before onset of malignant neoplasm of the endometrium
[72] clikpopup://CCPS/reject14107No
[73] clikpopup://CCPS/reject14061No